RHO and urogenital neoplasm: We previously reported that increased activity or overexpression of Rho and ROCK were associated with local invasion, metastasis, and an unfavorable prognosis of urogenital cancer including urothelial cancer [21-23], indicating that the Rho/ROCK pathway may be a potential target for anticancer therapy.